FISH investigation of 5q and 7q deletions in MDS/AML reveals hidden translocations, insertions and fragmentations of the same chromosomes

Leukemia Research

Volumn 22, Issue 4, 1998, Pages 303-312

  Lessard, Michel ^a   Herry, Angèle ^a   Berthou, Christian ^a   Léglise, Marie Chantal ^a   Abgrall, Jean François ^a   Morice, Patrick ^b   Flandrin, Georges ^c  

^a BREST UNIVERSITY HOSPITAL   (France)

^b Service d'Hematologie   (France)

^c Laboratoire Central d'Hematologie   (France)

Author keywords

Chromosomes 5 and 7 long arm deletions; Fragmentation; Hidden translocations; Insertions; MDS AML

Indexed keywords

DNA FRAGMENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER GENETICS; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CHROMOSOME DELETION 5; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE INSERTION; HUMAN; HUMAN CELL; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; SCHOOL CHILD;

ACUTE DISEASE; AGED; CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; CHROMOSOMES, HUMAN, PAIR 7; DNA FRAGMENTATION; DNA TRANSPOSABLE ELEMENTS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; TRANSLOCATION, GENETIC;

EID: 0032052825     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00172-0     Document Type: Article

References (45)

1. [1] van den Berghe H. Cassiman JJ, David G, Fryns JP, Michaux JL, Sokal G. Distinct hematological disorder with deletion of long arm of no 5 chromosome. Nature 1974;251:437.
2. [2] van den Berghe H, Vermaelen K, Mecucci C, Barbieri D, Tricot G. The 5q - anomaly. Cancer Genet Cytogenet 1985;17:189.
3. [3] van den Berghe H, Michaux L. 5q - , twenty-five years later: a synopsis. Cancer Genet Cytogenet 1996;94:1.
4. [4] Nimer SD, Golde DW. The 5q - abnormality.' Blood 1987;70:1705.
5. [5] Sandberg AA. The Chromosomes in Human Cancer and Leukemia. 2nd ed. New York: Elsevier, 1990:1315.
6. [6] Boultwood J, Lewis S, Wainscoat JS. The 5q - syndrome. Blood 1994;84:3253.
7. [7] Heim S, Mitelman F. Cancer Cytogenetics. 2nd ed. New York: Wiley, 1995:536.
8. [8] Rowley JD, Golomb HM, Vardiman JW. Nonrandom chromosomal abnormalities in acute nonlymphocytic leukemia in patients treated for Hodgkin's disease and non-Hodgkin's lymphoma. Blood 1977;50:759.
9. [9] Mitelman F, Nilsson PG, Brandt L, Alimena G, Gastaldi R, Dallapiccoia B. Chromosome pattern, occupation and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1981;4:197.
10. [10] Groupe Français de Cytogénétique Hématologique. Chromosome analysis of 63 cases of secondary nonlymphoid blood disorders: a cooperative study. Cancer Genet Cytogenet 1984;12:95.
11. [11] Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD. Clinical and cytogenetic correlations in 63 patients with therapy related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no5 and 7. J Clin Oncol 1986;4:325.
12. [12] Bennett JM. Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes: French-American-British (FAB) co-operative group. Br J Haematol 1982;51:189.
13. [13] Webber LM. Garson OM. Fluorodeoxyuridine synchronization of bone marrow cultures. Cancer Genet Cytogenet 1983;8:123.
14. [14] Sehested J. A simple method for R banding of human chromosomes, showing a pH-dependent connection between R and G bands. Humangenetik 1974;21:53.
15. [15] ISCN. International System for Human Cytogenetic Nomenclature. Mitelman FS, editor. Basel: Karger, 1995:114.
16. [16] Wang MR, Perissel B, Malet P. Rehybridization on metaphase studied previously by FISH. Cancer Genet Cytogenet 1995;85:58.
17. [17] Gibbons B, Lillington DM, Monard S, Young BD, Cheung KL, Lister TA, Kearney L. Fluorescence in situ hybridisation studies to characterise complete and partial monosomy 7 in myeloid disorders. Genes Chromosomes Cancer 1994;10:244.
18. [18] Tosi S, Harbott J, Haas OA, Douglas A, Hugues DM, Ross FM, Biondi A, Scherer SW, Kearney L. Classification of deletions and identification of cryptic transiocations involving 7q by fluorescence in situ hybridization (FISH). Leukemia 1996;10:644.
19. [19] Thangavelu M, Bitter MA, Larson RA, Davis EM, Rowley JD, Le Beau MM. der(5) t(5;7)(q11.2;p11.2): A new recurring abnormality in malignant myeloid disorders. Cancer Genet Cytogenet 1989;37:1.
20. [20] Scheres JMJC, Hustinx TWJ, Haldrinet RSG, Geraedts JPM, Hagemeijer A, Van der Blij Philipsen M. Translocation 1:7 in dyshematopoiesis: possibly induced with a nonrandom geographic distribution. Cancer Genet Cytogenet 1984;12:283.
21. [21] Laï JL, Zandecki M, Fenaux P, Le Baron F, Bauters F, Cosson A, Deminatti M. Translocation (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. Cancer Genet Cytogenet 1990;46:173.
22. [22] Johansson B, Arheden K, Hoglund M, Othzen A, Bekassy AN, Turesson I, Heim S, Mitelman F. Fluorescence in situ hybridization analysis of whole-arm translocations in hematologic malignancies. Genes Chromosomes Cancer 1995;14:56.
23. [23] Viguié F, Prigent Y, Ramond S, Baumelou E, Cadiou M, Dreyfus F, Zittoun R. Fluorescence in situ hybridization analysis of minute marker chromosomes in leukemia with monosomy 7. Leukemia 1995;9:1154.
24. [24] Cremer T, Popp S, Emmerich P, Lichter P, Cremer C. Rapid metaphase and interphase detection of radiation-induced chromosome aberrations in human lymphocytes by chromosomal suppression in situ hybridization. Cytometry 1990;11:110.
25. [25] Le Beau MM, Espinosa III R, Neuman WL, Stock W, Roulston D, Larson RA, Keinanen M, Westbrook C. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proc Nat Acad Sci USA 1993;90:5484.
26. [26] Boultwood J, Fidler C, Lewis S, Kelly S, Sheridan H, Littlewood TJ, Buckle VJ, Wainscoat JS. Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q -syndrome: delineation of the critical region on 5q and identification of a 5q-breakpoint. Genomics 1994;19:425.
27. [27] Fairman J, Chumakov I, Graig Chinault A, Nowell PC, Nagarajan L. Physical mapping of the minimal region of loss in 5q -chromosome. Proc Nat Acad Sci USA 1995;92:7406.
28. [28] Lewis S, Oscier D, Boultwood J, Ross F, Fitchett M, Rack K, Abrahamson G, Buckle V, Wainscoat JS. Haematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletions. Am J Hematol 1995;49:194.
29. [29] Le Beau MM, Espinosa III R, Davis EM, Eisenbard JD, Larson RA, Green D. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid disease. Blood 1996;88:1930.
30. [30] Nagarajan L. Molecular analysis of the 5q - chromosome. Leuk Lymphoma 1995;17:361.
31. [31] Boultwood J, Rack C, Kelly S, Madden J, Sakaguchi AY, Wang LM, Oscier DG, Buckle VJ, Wainscoat JS. Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion. Proc Nat Acad Sci USA 1991;88:6176.
32. [32] Nagarajan L, Zavadil J, Claxton D, Lu X, Fairman J, Warrington JA, Wasmuth JJ, Chinault AC, Sever CE, Slovak ML. Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q - chromosome. Blood 1994;83:199.
33. [33] Tigaud I, Charrin C, Berger R, Jonveaux P. Partial deletion of the long arm of chromosome 5: a fluorescence in situ hybridization study using band-specific painting probes generated by chromosome microdissection. Cancer Genet Cytogenet 1996;89:126.
34. [34] Pedersen B. Anatomy of the 5q - deletion: different sex ratios and deleted 5q bands in MDS and AML. Leukemia 1996;10:1883.
35. [35] Nagarajan L, Zhao L, Lu X, Warrington JA, Wasmuth JJ, Siciliano M, Deisseroth AB, Liang JC. 5q - chromosome. Evidence for complex interstitial breaks in a case of refractory anemia with excess blasts. Cancer Genet Cytogenet 1996;74:8.
36. [36] Fairman J, Wang RY, Liang H, Zhao L, Saltman D, Liang JC, Nagarajan L. Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus. Blood 1996;88:2259.
37. [37] Johnson EJ, Scherer SW, Osborne L, Tsui LC, Oscier D, Mould S, Cotter FE. Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia. Blood 1996;87:3579.
38. [38] Velloso ER, Michaux L, Ferrant A, Hernandez JM, Meeus P, Dierlamm J, Criel A, Louwagie A, Verhoef G. Boogaerts M, Michaux JL, Bosly A, Mecucci C, van den Berghe H. Deletions of the long arm of chromosome 7 in myeloid disorders: loss of band 7q32 implies worst prognosis. Br J Haematol 1996;92:574.
39. [39] Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994;77:307.
40. [40] Yoneda-Kato N, Look AT, Kirstein MN, Valentine MB, Raimondi SC, Cohen KJ, Carroll AJ, Morris SW. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produce a novel fusion gene, NPM-MLF1. Oncogene 1996;12:265.
41. [41] Pedersen-Bjergaard J, Philip P. Balanced translocation involving chromosome band 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II. Blood 1991;78:1147.
42. [42] Pedersen-Bjergaard J, Rowley JD. The balanced and unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994;83:2780.
43. [43] Schröck E, du Manoir S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. Multicolor spectral karyotyping of human chromosomes. Science 1996;273:494.
44. [44] Speicher MR, Gwyn Balard S, Ward DC. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 1996;12:368.
45. [45] Veldman T, Vignon C, Schröck E, Rowley JD, Ried T. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 1997;15:406.